Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Single-cell genomic analysis of triple-negative breast cancer fibroblasts uncovers evolutionarily conserved features and potential therapeutic targets

Ana Paula Delgado, Alice Nemajerova, Manisha Rao, Jinyu Li, Natalia Marchenko, Jonathan Preall, Ute M. Moll, Mikala Egeblad, Scott Powers
doi: https://doi.org/10.1101/2022.05.05.490693
Ana Paula Delgado
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
2Graduate Program in Genetics, Stony Brook University, Stony Brook, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice Nemajerova
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manisha Rao
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinyu Li
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Marchenko
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Preall
3Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ute M. Moll
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikala Egeblad
2Graduate Program in Genetics, Stony Brook University, Stony Brook, New York
3Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Powers
1Department of Pathology and Cancer Center, Renaissance School of Medicine, Stony Brook, New York
2Graduate Program in Genetics, Stony Brook University, Stony Brook, New York
3Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: scott.powers@stonybrook.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Summary

To explore cancer associated fibroblasts (CAFs) in triple-negative breast cancers (TNBC), we performed scRNA-seq analysis of fibroblasts from murine and human TNBCs. We observed three distinct CAF subtypes in mouse TNBC: two that are intermingled and adjacent to tumor cells, and one that is more distal. We present evidence that progression of CAFs from normal resident fibroblasts/pericytes involves upregulation of their Pdgf and Tgfb receptors along with reciprocal ligand upregulation in other cells within the tumor microenvironment. Additionally, extracellular matrix, glycolytic, and mitochondrial respiratory genes are strongly upregulated in all CAFs. Activation of extracellular matrix genes specifically in CAFs and not in normal fibroblasts provides numerous targets for CAF-based therapeutics, many of which are conserved in CAFs from human TNBC. In contrast, the subtype structure of CAFs was less conserved, which along with their transcriptional heterogeneity suggests that molecular targeting of CAFs is more practical than targeting CAF subtypes.

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 10, 2022.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Single-cell genomic analysis of triple-negative breast cancer fibroblasts uncovers evolutionarily conserved features and potential therapeutic targets
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Single-cell genomic analysis of triple-negative breast cancer fibroblasts uncovers evolutionarily conserved features and potential therapeutic targets
Ana Paula Delgado, Alice Nemajerova, Manisha Rao, Jinyu Li, Natalia Marchenko, Jonathan Preall, Ute M. Moll, Mikala Egeblad, Scott Powers
bioRxiv 2022.05.05.490693; doi: https://doi.org/10.1101/2022.05.05.490693
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Single-cell genomic analysis of triple-negative breast cancer fibroblasts uncovers evolutionarily conserved features and potential therapeutic targets
Ana Paula Delgado, Alice Nemajerova, Manisha Rao, Jinyu Li, Natalia Marchenko, Jonathan Preall, Ute M. Moll, Mikala Egeblad, Scott Powers
bioRxiv 2022.05.05.490693; doi: https://doi.org/10.1101/2022.05.05.490693

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4845)
  • Biochemistry (10777)
  • Bioengineering (8034)
  • Bioinformatics (27257)
  • Biophysics (13964)
  • Cancer Biology (11115)
  • Cell Biology (16034)
  • Clinical Trials (138)
  • Developmental Biology (8772)
  • Ecology (13269)
  • Epidemiology (2067)
  • Evolutionary Biology (17342)
  • Genetics (11680)
  • Genomics (15904)
  • Immunology (11013)
  • Microbiology (26045)
  • Molecular Biology (10627)
  • Neuroscience (56465)
  • Paleontology (417)
  • Pathology (1729)
  • Pharmacology and Toxicology (2999)
  • Physiology (4539)
  • Plant Biology (9615)
  • Scientific Communication and Education (1613)
  • Synthetic Biology (2684)
  • Systems Biology (6968)
  • Zoology (1508)